Home > Insider Trading > Filing (0001140361-12-005669)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1037760	Cepheid	CPHD	Laboratory Analytical Instruments (3826)	770441625

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1319606	Andrew Miller	C/O Cepheid 904 Caribbean Drive Sunnyvale CA 94089	Evp, Cfo	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2012-02-02	48,875	$21.00	54,098	No	4	M	Direct
Common Stock	Acquisiton	2012-02-02	3,287	$8.43	57,385	No	4	M	Direct
Common Stock	Disposition	2012-02-02	52,162	$43.15	5,223	No	4	S	Direct
Common Stock	Acquisiton	2012-02-03	4,213	$8.43	9,436	No	4	M	Direct
Common Stock	Acquisiton	2012-02-03	5,687	$20.47	15,123	No	4	M	Direct
Common Stock	Disposition	2012-02-03	9,900	$43.16	5,223	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2012-02-02	48,875	$0.00	48,875	$21.00
Common Stock	Non-Qualified Stock Option (Right to Buy)	Disposition	2012-02-02	3,287	$0.00	3,287	$8.43
Common Stock	Non-Qualified Stock Option (Right to Buy)	Disposition	2012-02-03	4,213	$0.00	4,213	$8.43
Common Stock	Non-Qualified Stock Option (Right to Buy)	Disposition	2012-02-03	5,687	$0.00	5,687	$20.47

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
12,500	2018-04-14	No	4	M	Direct
16,713	2016-04-28	No	4	M	Direct
12,500	2016-04-28	No	4	M	Direct
21,938	2017-04-29	No	4	M	Direct

Footnotes

Represents the aggregate of sales effected on the same day at different prices.
Represents the weighted average sales price per share. The shares sold at prices ranging from $43.00 to $43.665 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
Represents the weighted average sales price per share. The shares sold at prices ranging from $43.15 to $43.27 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
25% of the shares subject to the grant vested and became exercisable on April 14, 2009; thereafter, 2.0833% of the shares subject to the grant vested or will vest and become exercisable on each monthly anniversay of the First Vesting Date until 100% vested.
25% of the shares subject to the grant vested and became exercisable on April 28, 2010; then 2.0833% of the shares vest and become exercisable on each monthly anniversary of the First Vesting Date until 100% vested.
25% of the shares subject to the grant vested and became exercisable on April 29, 2011; thereafter, 2.0833% of the shares subject to the grant vested or will vest and become exercisable on each monthly anniversay of the First Vesting Date until 100% vested.